Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00595153 · ClinicalTrials.gov registry record · Phase 1
Study of the Mechanisms of Asthma
A Phase 1 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 1
- Development phase
- 127
- Enrollment target
NCT00595153 is a Phase 1 study that has completed, run by University of California, San Francisco. The registered enrollment target is 127 participants.
The verdict
NCT00595153, a Phase 1 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 127 participants
- Enrollment target
Study Summary
The purpose of this study is to identify the causes of asthma that were not previously suspected, to better understand the effects of inhaled steroids on asthma and to identify new way to treat asthma. In order to take advantage of the most current scientific expertise, we (scientists at UCSF) plan to work together with Genentech Inc. We believe that working with Genentech will provide the best chance of developing new treatments for asthma.
Interventions
- DRUG Pulmicort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2007-04 |
| Est. Completion | 2011-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00595153
The ClinicalTrials.gov registry entry for NCT00595153 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pulmicort is the first listed.
NCT00595153 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00595153 about?
NCT00595153 is a clinical study titled "Study of the Mechanisms of Asthma". The purpose of this study is to identify the causes of asthma that were not previously suspected, to better understand the effects of inhaled steroids on asthma and to identify new way to treat asthma. In order to take advantage of the most current scientific expertise, we (scientists at UCSF) plan ...
What is the current status of trial NCT00595153?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 127 participants. The study started on 2007-04. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00595153?
The interventions under investigation include: Pulmicort (DRUG).
Who is sponsoring clinical trial NCT00595153?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.